pfizer inc (PFE*:Mexico)
Transactions by PFIZER INC (PFE*) in the last 6 months
Pfizer Inc. (NYSE:PFE) acquired a controlling stake in Redvax GmbH from Redbiotec AG on January 5, 2015.
Pfizer Inc. (NYSE:PFE) entered into an agreement to acquire worldwide licenses of hGH-CTP from Opko Health, Inc. (NYSE:OPK) for $570 million on December 13, 2014. Under the terms of the agreement, Opko Health will receive an upfront payment of $295 million and is eligible to receive up to an additional $275 million upon the achievement of certain regulatory milestones. Pfizer will receive the exclusive license to commercialize hGH-CTP worldwide. The transaction is subject ...
iTeos Therapeutics SA announced that it will receive equity funding from Pfizer Inc. on December 8, 2014.
Pfizer Inc. (NYSE:PFE) announces a share repurchase program. Under the program, the company will repurchase up to $11 billion worth of its shares. The plan will be utilized over time. The Board of Directors of Pfizer Inc. has authorized a buyback plan on October 23, 2014. On October 23, 2014, the company initiated a Market Repurchase.
|Bayer AG||€128.11 EUR||-1.40|
|Gilead Sciences Inc||$106.09 USD||-1.02|
|Johnson & Johnson||$102.63 USD||+0.37|
|Novartis AG||SFr.88.85 CHF||+1.85|
|Procter & Gamble Co/The||$86.58 USD||-3.00|
|View Industry Companies|